Evidence mapPaperPMID 33071727Full record

ArticleFrontiers in neuroscience2020

Identification of a Novel CCM1 Frameshift Mutation in a Chinese Han Family With Multiple Cerebral Cavernous Malformations.

Fan Zhang, Yiteng Xue, Feng Zhang, Xiaoming Wei, Zhisong Zhou, Zhaoru Ma, Xiaosong Wang, Hong Shen, Yujun Li, Xiaoying Cui and 1 more

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Fan ZhangDepartment of Anesthesiology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Yiteng XueDepartment of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Feng ZhangDepartment of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Xiaoming WeiDepartment of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Zhisong ZhouDepartment of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Zhaoru MaDepartment of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Xiaosong WangDepartment of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Hong ShenDepartment of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Yujun LiDepartment of Microbiology and Wu Lien-Teh Institute, Harbin Medical University, Harbin, China.
Xiaoying CuiQueensland Brain Institute, The University of Queensland, St Lucia, QLD, Australia.
Li LiuDepartment of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerebral cavernous malformations (CCMs) are vascular lesions that predominantly occur in the brain. CCMs can be sporadic or hereditary in an autosomal dominant manner. The genes harboring variants of familial CCMs (FCCMs) include CCM1/KRIT1, CCM2/MGC4607, and CCM3/PDCD10. In this study, we identified a novel CCM1/KRIT1 mutation in a Chinese family with FCCMs. This family consists of 20 members, and 6 of them had been diagnosed with CCMs. The proband patient is a 17-year-old female who has suffered from CCM-related intracranial hemorrhage four times. Magnetic resonance imaging (MRI) revealed four lesions in the different brain regions and one lesion has progressively enlarged. The pathological histology confirmed CCMs. Whole exome sequencing revealed a novel deletion mutation (c.1635delA) within exon 15 of CCM1/KRIT1 gene in the proband patient, her mother, and her uncle who had CCMs. This frameshift mutation led to a premature termination codon (PTC) at nucleotides 1652-1654. We also detected that the CCM1 mRNA levels in the blood lymphocytes of the family members with CCMs were reduced by 46.4% compared to that in healthy controls. Collectively, our results suggested that the CCM1 mutation could potentially be a causative factor for FCCMs in the Chinese family and the reduction of CCM1 mRNA expression in the blood lymphocytes of the patients might be a potential biomarker for the diagnosis and prognosis of CCMs. Our findings expanded the spectrum of CCM mutations and helped to guide genetic counseling and early genetic diagnosis for at-risk family members.

Indexed as

CCM1FCCMsframeshift deletionhemorrhagetruncated protein

Identifiers

PMID33071727
PMCPMC7538688

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.